Listar por tema "highly active antiretroviral therapy"

Mostrando ítems 1-11 de 11

Acalculous Cholecystitis caused by Histoplasma capsulatum in a severely immunosuppressed HIV-infected patient

Alave, J.; Bustamante Rufino, Ana Beatriz; Soto, L.; Cáceres, J.; Seas Ramos, Carlos Rafael (Journal of Infection in Developing Countries, 2011)

Billiary tract involvement in the course of disseminated histoplasmosis has been rarely reported. Here we present a severely immunosuppressed HIV-infected patient who presented with symptomatic acalculous cholecystitis ...
Clinical and Virologic Outcomes after Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network

Wolff, M.; Shepherd, B.E.; Cortés, C.; Rebeiro, P.; Cesar, C.; Wagner Cardoso, S.; Pape, J.W.; Padgett, D.; Sierra-Madero, J.; Echevarria Zarate, Juan Ignacio; McGowan, C.C.; CCASAnet (Wolters Kluwer Health, 2016)

Background: HIV-infected persons in resource-limited settings may experience high rates of antiretroviral therapy (ART) change, particularly because of toxicity or other nonfailure reasons. Few reports address patient ...
Counseling for improving adherence to antiretroviral treatment: a systematic review

Musayón Oblitas, Flor Yesenia; Cárcamo Cavagnaro, César Paul Eugenio; Gimbel, Sarah (Taylor and Francis, 2018)

One-on-one counseling can be an effective strategy to improve patient adherence to HIV treatment. The aim of this systematic review is to examine articles with one-on-one counseling-based interventions, review their ...
Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America

Cesar, C.; Koethe, J.R.; Giganti, M.J.; Rebeiro, P.; Althoff, K.N.; Napravnik, S.; Mayor, A.; Grinsztejn, B.; Wolff, M.; Padgett, D.; Sierra Madero, J.; Gotuzzo Herencia, José Eduardo; Sterling, T.R.; Willig, J.; Levison, J.; Kitahata, M.; Rodriguez-Barradas, M.C.; Moore, R.D.; McGowan, C.; Shepherd, B.E.; Cahn, P. (Wiley, 2016)

Introduction: Latinos living with HIV in the Americas share a common ethnic and cultural heritage. In North America, Latinos have a relatively high rate of new HIV infections but lower rates of engagement at all stages of ...
Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: An observational cohort study

Cesar, C.; Jenkins, C.A.; Shepherd, B.E.; Padgett, D.; Mejía Cordero, Fernando Alonso; Ribeiro, S.R.; Cortes, C.P.; Pape, J.W.; Sierra Madero, J.; Fink, V.; Sued, O.; McGowan, C.; Cahn, P.; Grinsztejn, B.; Reyes, M.W.; Gotuzzo Herencia, José Eduardo; CCASAnet (Elsevier, 2015)

Background: Access to combination antiretroviral therapy (ART) is expanding in Latin America (Mexico, Central America, and South America) and the Caribbean. We assessed the incidence of and factors associated with regimen ...
Monitoring of HIV treatment in seven countries in the WHO region of the Americas

Belaunzarán-Zamudio, P.F.; Caro-Vega, Y.N.; Shepherd, B.E.; Crabtree-Ramírez, B.E.; Luz, P.M.; Grinsztejn, B.; Cesar, C.; Cahn, P.; Cortés, C.; Wolff, M.; Pape, J.W.; Padgett, D.; Gotuzzo Herencia, José Eduardo; McGowan, C.; Sierra-Madero, J.G.; CCASAnet (World Health Organization, 2015)

Objective: To determine the prevalence of adequate monitoring and the costs of measuring CD4+ T-lymphocytes (CD4+ cell) and human immunodeficiency virus (HIV) viral load in people receiving antiretroviral therapy (ART) in ...
Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean

Carriquiry, G.; Fink, V.; Koethe, J.R.; Giganti, M.J.; Jayathilake, K.; Blevins, M.; Cahn, P.; Grinsztejn, B.; Wolff, M.; Pape, J.W.; Padgett, D.; Sierra Madero, J.; Gotuzzo Herencia, José Eduardo; McGowan, C.C.; Shepherd, B.E. (Wiley, 2015)

Introduction: Long-term survival of HIV patients after initiating highly active antiretroviral therapy (ART) has not been sufficiently described in Latin America and the Caribbean, as compared to other regions. The aim of ...
The Potential Impact of Pre-Exposure Prophylaxis for HIV Prevention among Men Who Have Sex with Men and Transwomen in Lima, Peru: A Mathematical Modelling Study

Gomez, G.B.; Borquez, A.; Caceres Palacios, Carlos Fernando; Segura, E.R.; Grant, R.M.; Garnett, G.P.; Hallett, T.B. (Public Library of Science, 2012)

Background: HIV pre-exposure prophylaxis (PrEP), the use of antiretroviral drugs by uninfected individuals to prevent HIV infection, has demonstrated effectiveness in preventing acquisition in a high-risk population of men ...
Síndrome de reconstitución inmune por BCG en niños tratados por VIH

Miranda-Choque, E.; Candela-Herrera, J.; Segura, E.R.; Farfán-Ramos, S.; Barriga, A. (Instituto Nacional de Salud, 2012)

The objective of this study is to describe the clinical profile of the immune reconstitution syndrome due to Mycobacterium bovis Bacillus Calmette-Guérin (IRS-BCG) in children with HIV infection who receive highly active ...
Time to HAART initiation after diagnosis and treatment of opportunistic infections in patients with AIDS in Latin America

Crabtree-Ramírez, B.; Caro-Vega, Y.; Shepherd, B.E.; Grinsztejn, B.; Wolff, M.; Cortes, C.P.; Padgett, D.; Carriquiry, G.; Fink, V.; Jayathilake, K.; Person, A.K.; McGowan, C.; Sierra-Madero, J.; CCASAnet (Public Library of Science, 2016)

Background: Since 2009, earlier initiation of highly active antiretroviral therapy (HAART) after an opportunistic infection (OI) has been recommended based on lower risks of death and AIDS-related progression found in ...
Universal definition of loss to follow-up in HIV treatment programs: A statistical analysis of 111 facilities in Africa, Asia, and Latin America

Chi, B.H.; Yiannoutsos, C.T.; Westfall, A.O.; Newman, J.E.; Zhou, J.; Cesar, C.; Brinkhof, M.W.G.; Mwango, A.; Balestre, E.; Carriquiry, G.; Sirisanthana, T.; Mukumbi, H.; Martin, J.N.; Grimsrud, A.; Bacon, M.; Thiebaut, R. (Public Library of Science, 2011)

Background: Although patient attrition is recognized as a threat to the long-term success of antiretroviral therapy programs worldwide, there is no universal definition for classifying patients as lost to follow-up (LTFU). ...

Listar por tema "highly active antiretroviral therapy"

Listar por tema "highly active antiretroviral therapy"

Buscar en el Repositorio

Listar

Todo el Repositorio

Panel de Control